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Macrolides are the antimicrobials of choice for treating human campylobacteriosis. The recent emergence of erm(B) in Campylo-
bacter bacteria threatens the utility of this class of antibiotics. Here we report the constitutive and inducible expression of
erm(B) in Campylobacter isolates derived from diarrheal patients and food-producing animals. Constitutive expression of
erm(B) was associated with insertion and deletion in the regulatory region of the gene, providing the first documentation of the
differential expression of erm(B) in Campylobacter bacteria.
Campylobacter bacteria are among the most common causes ofbacterium-mediated diarrheal disease worldwide (1). Addi-
tionally, Campylobacter infection can lead to extraintestinal com-
plications such as polyarthralgia (i.e., reactive arthritis) and Guil-
lain-Barré syndrome (2). In general, the occurrence of human
Campylobacter infection has been attributed largely to the con-
sumption of contaminated food animal products, resulting from
the high prevalence of Campylobacter in these animals (3).
Erythromycin, a 14-membered macrolide antibiotic, is recom-
mended for use as the first-line treatment of campylobacteriosis
(4), while 16-membered macrolides (e.g., tylosin and spiramycin)
are some of the most common growth-promoting agents in food
animal production worldwide (5). Macrolide resistance among
Campylobacter jejuni and Campylobacter coli strains is generally
much more severe in developing countries than in developed
countries (5–9). In addition, there is a much higher frequency of
macrolide resistance in C. coli than that in C. jejuni, both in iso-
lates derived from humans and in those from food animals (6, 10,
11). Very recently, the rRNA methylase Erm(B) has emerged as an
important mechanism of acquired macrolide-lincosamide (ML)
resistance inC. jejuni andC. coli (8, 12, 13), the two most common
human disease-causing Campylobacter species. In Gram-positive
bacteria, the expression of erm genes can be either constitutive or
inducible (14). The mechanism of erm(B) induction has not been
thoroughly investigated (14); however, the induction of erm(C)
has been well studied and it is believed to be due to structural
alterations, including sequence deletions, duplications/insertions,
and point mutations in the erm(C) regulatory region, which acts
as a translational attenuator (15). To our knowledge, no informa-
tion is available concerning the mechanism of erm(B) induction in
Campylobacter bacteria.
This study included 29 Campylobacter strains with a chromo-
some-borne erm(B) gene (28 of C. coli, 1 of C. jejuni), 27 of which
were collected during 2007 to 2012 from food-producing animals
(chickens, swine, and ducks) and diarrheal patients in different
provinces and cities in China (8) and 2 of which (DZB40 and 86c)
were collected in 2013 from swine slaughterhouses in Shandong
and Guangdong, respectively. Details of the origins and identifi-
cation of the above-mentioned 27 Campylobacter strains have
been described previously (8).
Campylobacter isolates were evaluated for susceptibility to 14-,
15-, and 16-membered macrolides, as well as clindamycin, by the
agar dilution method with incubation at 42°C for 24 h under mi-
croaerophilic conditions according to CLSI document VET01-A4
(16). C. jejuni ATCC 33560 was used as a quality control strain. To
determine MICs following induction, isolates were grown on Mu-
eller-Hinton agar containing either erythromycin at 0.5 mg/liter
or clindamycin at 0.25 mg/liter. Three independent experiments
were conducted to confirm the reproducibility of the MIC pat-
terns.
The erm(B)-positive Campylobacter strains were classified as
having a constitutive ML antibiotic resistance phenotype if resis-
tance was independent of preincubation with the inducer, while
inducible resistance was dependent on preincubation (Table 1).
Inducible-erm(B)-positiveC. coli strains DZB40 and 86c were sus-
ceptible to all of the antibiotics tested, except for tylosin, prior to
induction. Following induction with erythromycin and clindamy-
cin independently, the two strains attained resistance to erythro-
mycin and azithromycin and also showed increased MICs of tylo-
sin (Table 1). This observation is consistent with previous findings
by other investigators (17, 18) and further suggests that some bac-
teria with inducible erm are susceptible to macrolides and lincos-
amides before induction, although isolates carrying erm(B)
usually exhibit ML resistance. Notably, the two inducible-erm(B)-
carrying strains did not show increased clindamycin MICs after
induction. This is similar to previous findings on erm(C) induc-
tion (19, 20), which showed that a strain expressing inducible
Received 19 May 2015 Returned for modification 10 June 2015
Accepted 6 August 2015
Accepted manuscript posted online 10 August 2015
Citation Deng F, Shen J, Zhang M, Wu C, Zhang Q, Wang Y. 2015. Constitutive and
inducible expression of the rRNA methylase gene erm(B) in Campylobacter.
Antimicrob Agents Chemother 59:6661–6664. doi:10.1128/AAC.01103-15.
Address correspondence to Yang Wang, wangyang@cau.edu.cn, or Qijing Zhang,
zhang123@iastate.edu.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
doi:10.1128/AAC.01103-15
October 2015 Volume 59 Number 10 aac.asm.org 6661Antimicrobial Agents and Chemotherapy
 o
n
 Septem
ber 26, 2017 by IO
W
A STATE UNIVERSITY
http://aac.asm
.org/
D
ow
nloaded from
 
erm(C) developed resistance only to 14- and 15-membered mac-
rolides and remained susceptible to lincosamides. In this study,
erythromycin and clindamycin were able to act as inducers of
erm(B) gene expression in Campylobacter to various degrees. The
MICs for the other 27Campylobacter strains were almost identical;
hence, the MICs for 7 epidemiologically distinct Campylobacter
strains, as representatives of the 27 Campylobacter strains, are
shown in Table 1. These 27 strains, including the only C. jejuni
strain (C179b), were highly resistant to ML antibiotics without
prior induction, indicating constitutive expression of erm(B).
Potential attenuators located within the regulatory region of
constitutively expressed erm(B) in Campylobacter isolates were
amplified by PCR as described previously and then sequenced
three times in both directions from independent replicons (21).
The inducibly expressed erm(B) regulatory region in Tn917 of
Enterococcus faecalis (GenBank accession no. M11180) was used as
the reference sequence. PCR amplification of the erm(B) regula-
tory regions, from the10 signal site to the 5= end of erm(B), of all
27 Campylobacter strains revealed the presence of two different
amplification products. The erm(B) regulatory region of DZB4
yielded an amplification product of 693 bp (GenBank accession
number KC876749), whereas the erm(B) regulatory regions of the
remaining 26 Campylobacter strains produced a smaller 61-bp
product (e.g., C179b, accession number KF864551) (Fig. 1). A
comparison with the equivalent region of the inducibly expressed
erm(B) gene of Tn917 is presented in Fig. 1. On the basis of this
comparison, the only difference was a 210-bp deletion in the reg-
ulatory region of C179b, compared with that of Tn917, that re-
moved the entire erm(B) attenuator. Several open reading frame
(ORFs) are present within the 210-bp deleted region, including an
ORF corresponding to a 27-amino-acid (aa) leader peptide that is
known to play a crucial role in the induction process as a partner
in mRNA secondary-structure formation (15). Moreover, the de-
letion of IR3 to IR7 renders IR8 accessible to ribosomes, indepen-
dent of the presence or absence of an inducer. The simultaneous
absence of the leader peptide and several inverted repeats (IRs)
from these 26 Campylobacter strains explains the observed consti-
tutive ML resistance.
C. coli isolate DZB4 contained a 635-bp substitution of the
three bases (GTT) at position 17 that are present in Tn917 (Fig. 1).
Sequence analysis revealed the presence of a novel 136-aa ORF,
fosXCC, in the 635-bp substitution, which was recently reported to
mediate resistance to fosfomycin in Campylobacter (22). As both
the leader peptide and IRs found in Tn917 were missing from the
erm(B) regulatory region of DZB4, the large substitution likely
had the same effect on erm(B) expression as the 210-bp deletion
that was detected in the other 26 Campylobacter strains. This kind
of large insertion in the erm regulatory region, causing a shift from
inducible to constitutive erm gene expression, was also observed
in the erm(A) regulatory region of Streptococcus agalactiae (17).
The possibility of the insertion of another antibiotic resistance
gene into the regulatory region, ensuring the transmission of the
multiple-drug resistance element into the genome ofCampylobac-
ter, is a cause for concern. However, the 635-bp substitution car-
rying the fosfomycin resistance gene fosXCC in DZB4 has not yet
been identified in any other Campylobacter strains.
In the two inducible erm(B)-positive C. coli strains DZB40 and
86c, a 27-aa leader peptide and four pairs of IRs (IR1 to IR8) were
detected in the erm(B) regulatory region, which could form stable
RNA secondary structures and modulate the expression of
erm(B). It has been reported that inducible erm expression was a
consequence of differences in mRNA base composition (14, 15).
Additionally, induction could cause erm expression by destabiliz-
ing mRNA secondary structures in the inducible erm strains (14,
15). The molecular and structural bases for the induction of
erm(B) in Campylobacter are unknown and remain to be deter-
mined in future studies. Interestingly, both DZB40 and 86c were
susceptible to most of the antibiotics tested prior to induction.
After induction, the MICs of macrolides substantially increased
but did not reach the levels of strains with constitutively expressed
erm(B) (Table 1). The coding sequence (CDS) of erm(B) in the
two isolates was intact and did not show any frame shift, substitu-
TABLE 1 MICs of ML antibiotics for Campylobacter strains determined with and without induction
Straina Hostb Regionc Typed
MIC (mg/liter)e
Erythromycin Azithromycin Tylosin
MIC (mg/liter)
Clindamycin
N I-e I-c N I-e I-c N I-e I-c N I-e I-c
C179b C GD C 512 512 512 128 128 128 1,024 1,024 1,024 512 512 512
ZP-GX-1 C SD C 256 256 256 256 256 256 1,024 1,024 1,024 512 512 512
ZC113 S SD C 512 512 512 256 256 256 1,024 1,024 1,024 1,024 1,024 1,024
DZB4 S SD C 256 256 256 128 128 128 1,024 1,024 1,024 1,024 1,024 1,024
DH67 D SD C 512 512 512 128 128 128 1,024 1,024 1,024 1,024 1,024 1,024
SH-CCD11C073 H SH C 512 512 512 128 128 128 1,024 1,024 1,024 1,024 1,024 1,024
HN-CCD07046 H HN C 256 256 256 256 256 256 1,024 1,024 1,024 1,024 1,024 1,024
DZB40 S SD I 2 32 16 0.25 8 4 8 128 32 1 1 1
86c S GD I 4 32 16 0.25 8 4 16 128 16 1 1 1
a All strains are C. coli, except C179b (C. jejuni). The first seven strains (except DZB40 and 86c) are representatives of the 27 Campylobacter strains collected from 2007 to 2012,
which have been described previously (8). The other 20 Campylobacter strains were 158, LH-GX-14, ZP-GX-12, ZP-GX-14, ZP-GX-20, ZP-GX-26, ZP-GX-28, ZP-GX-35, ZP-GX-
36, ZP-GX-37, ZP-GX-5, ZP-GX-8, SH-CCD11C226, SH-CCD11C287, SH-CCD11C365, SH-CCD11C416, SH-CCD11C419, SH-CCD11C490, SH-CCD11C518, and SH-
CCD11C682.
b C, chicken; S, swine; D, duck; H, human.
c GD, Guangdong Province; SD, Shandong Province; SH, Shanghai Municipality; HN, Henan Province.
d C, constitutive; I, inducible.
e The erythromycin, azithromycin, tylosin, and clindamycin MIC breakpoints were all8 mg/liter. N, not induced; I-e, induced with erythromycin; I-c, induced with clindamycin.
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tion, or sequence deletion that might affect the MICs. Thus, the
lower MICs could not be explained by alteration of the CDS. It is
possible that inducible erm(B) is not expressed at a level as high as
that of constitutive erm(B) and thus confers only an intermediate
level of resistance.
In conclusion, constitutive erm(B) gene expression in Campy-
lobacter was more prevalent, probably because of the use of eryth-
romycin and tylosin for therapeutic purposes and growth promo-
tion in food-producing animals. The data obtained in this study
suggest that constitutively expressed erm(B) of Campylobacter
might have evolved from inducibly expressed erm(B) (e.g., Tn917)
following deletion or recombination in the regulatory region.
Moreover, the 210-bp deletion in the constitutively expressed
erm(B) regulatory region was consistently detected in the chro-
mosomal DNA of 26 epidemiologically distinct C. coli and C. je-
juni strains isolated from humans and food-producing animals,
suggesting the presence of a common mechanism for constitutive
expression. Additionally, erm(B)-positive Campylobacter strains
that are susceptible to ML antibiotics, such as the inducible
erm(B)-positive Campylobacter strain investigated in this study,
pose a hidden risk to public health, as they would not be detected
by diagnostic methods that rely only on the resistance phenotype.
Furthermore, inducible erm(B)-positive Campylobacter bacteria
in the intestines of humans and food-producing animals treated
for extensive periods with the appropriate inducer antibiotics
might increase the reservoir of resistant Campylobacter bacteria.
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